Research News

Researchers uncover aspirin’s effects on platelet rich plasmaMar 19, 2019
A collaborative study led by researchers at Baylor College of Medicine explores the effects of aspirin on a new biologic therapy, platelet rich plasma (PRP).
Autism study focuses on underrepresented communitiesMar 14, 2019
A new grant to Baylor College of Medicine will build on the ongoing SPARK for Autism research study by focusing on fighting disparities and lack of diversity in autism research.
Study of LDL lowering drug found no increase of adverse eventsMar 13, 2019
A study looking at safety of a new drug has found it does not increase overall adverse events or serious adverse events when compared to placebo.
Researchers: tool can identify human trafficking victimsFeb 19, 2019
Researchers report a screening tool designed specifically to assess for human trafficking was more likely to identify sexual and labor exploitation of youth than a commonly used psychosocial assessment.
PreSeek can complement genetic disease prenatal screeningJan 28, 2019
PreSeek can provide valuable molecular information for the detection of a wide spectrum of dominant monogenic diseases, according to an initial study.
Global grants aim to help scientists understand tumor behaviorJan 23, 2019
A multidisciplinary, international team of scientists has been awarded Cancer Research UK’s Grand Challenge, an ambitious series of £20 million global grants tackling some of the toughest questions in cancer research.
Fungi cause brain infection and memory impairment in miceJan 4, 2019
Researchers at Baylor College of Medicine has developed a mouse model to study the short-term consequences of fungal infection in the brain.
Volunteers needed for Alzheimer’s researchDec 11, 2018
Researchers are seeking clinical trial volunteers for new Alzheimer’s disease prevention and treatment studies.
FDA recognizes database of clinically relevant genetic variantsDec 5, 2018
The database created by the Clinical Genome Resource program (ClinGen) has been recognized by the U.S. Food and Drug Administration.
DPYSL3 an outlier gene in triple-negative breast cancerNov 26, 2018
Researchers have developed an entirely new therapeutic hypothesis on how to treat an aggressive form of triple-negative breast cancer.